4.7 Article

Motoric cognitive risk syndrome Multicountry prevalence and dementia risk

Journal

NEUROLOGY
Volume 83, Issue 8, Pages 718-726

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0000000000000717

Keywords

-

Funding

  1. Australian National Health and Medical Research Council [403000]
  2. Canadian Institutes of Health and Research [MOP 211220]
  3. NIH
  4. WHO (OGHA) [04034785, YA1323-08-CN-0020, Y1-AG-1005-01, R01 AG034479, 1R21AG034263]
  5. French Ministry of Health (Projet Hospitalier de Recherche Clinique national) [2009-A00533-54]
  6. NIH [R01 AG039330, AG-14100, 263 MD 916413, 263 MD 821336, 1ZIAAG001050, R00AG037574, 1P01AG034906, R01AG046949, 1R01AG042188, P30AG038072, NIH R37AG18381, R01AG036921, RO1AGO44007-01A1, P30AG10161, R01AG15819, R01AG17917, R01AG34374, R01AG33678, RO1 AG10939, RO3 AG026106]
  7. Italian Ministry of Health [ICS 110.1/RS97.71]
  8. Kurihara, Miyagi, Japan
  9. Korean Health Technology R D Project [A092077, A070001]
  10. National Research Foundation of Korea [2012-0000999]
  11. UK NIHR Biomedical Research Centre for Ageing and Age-Related Disease award
  12. Department of Health
  13. Parkinson's UK programme grant [J-0802]
  14. CTSA [KL2TR000088]
  15. Einstein Glenn Center
  16. Paul Glenn Foundation
  17. American Federation for Aging Research
  18. Illinois Department of Public Health

Ask authors/readers for more resources

Objectives: Our objective is to report prevalence of motoric cognitive risk syndrome (MCR), a newly described predementia syndrome characterized by slow gait and cognitive complaints, in multiple countries, and its association with dementia risk. Methods: Pooled MCR prevalence analysis of individual data from 26,802 adults without dementia and disability aged 60 years and older from 22 cohorts from 17 countries. We also examined risk of incident cognitive impairment (Mini-Mental State Examination decline >= 4 points) and dementia associated with MCR in 4,812 individuals without dementia with baseline Mini-Mental State Examination scores >= 25 from 4 prospective cohort studies using Cox models adjusted for potential confounders. Results: At baseline, 2,808 of the 26,802 participants met MCR criteria. Pooled MCR prevalence was 9.7% (95% confidence interval [CI] 8.2%-11.2%). MCR prevalence was higher with older age but there were no sex differences. MCR predicted risk of developing incident cognitive impairment in the pooled sample (adjusted hazard ratio [aHR] 2.0, 95% CI 1.7-2.4); aHRs were 1.5 to 2.7 in the individual cohorts. MCR also predicted dementia in the pooled sample (aHR 1.9, 95% CI 1.5-2.3). The results persisted even after excluding participants with possible cognitive impairment, accounting for early dementia, and diagnostic overlap with other predementia syndromes. Conclusion: MCR is common in older adults, and is a strong and early risk factor for cognitive decline. This clinical approach can be easily applied to identify high-risk seniors in a wide variety of settings.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available